SURVEY OF GRAFT KIDNEY FUNCTION CHARACTERISTICS AND SOME RELATED FACTORS IN KIDNEY TRANSPLANT RECIPIENTS AT MILITARY HOSPITAL 175
DOI:
https://doi.org/10.59459/1859-1655/JMM.935Từ khóa:
End-stage chronic kidney disease, kidney transplantation, kidney functionTóm tắt
Objective: To evaluate early graft kidney function and influencing factors in living-donor kidney transplant recipients.
Subjects and Methods: A prospective descriptive study was conducted on 52 living-donor kidney transplant recipients at Military Hospital 175 from July, 2023 to May, 2025. Assessment of graft function post‑transplant by serum creatinine concentration and GFR during the first three months after kidney transplantation.
Results: Most kidney recipients were male (65.4%), with a mean age of 42.3 ± 12.2 years. The mean age of kidney donors was 35.7 ± 7.2 years, and the mean HLA mismatch was 2.8 ± 1.2. Estimated glomerular filtration rate (eGFR) at one month and three months post-transplant was 67.2 ± 16.3 ml/min/1.73m² and 63.8 ± 15.9 ml/min/1.73m², respectively, with no statistically significant difference. Recipient age over 50 years and an age difference greater than 10 years between donor and recipient were associated with lower estimated glomerular filtration rate (eGFR) at one month post-transplant. Among recipients with Tacrolimus concentrations > 5 ng/ml, rapid Tacrolimus metabolizers had a lower estimated glomerular filtration rate (eGFR) at 3 months post-transplant compared with slow or intermediate metabolizers (55.8 ml/min/1.73 m² versus 67.1 ml/min/1.73 m²; p = 0.015). The change in estimated glomerular filtration rate (eGFR) was also less favorable in the rapid metabolizer group (-8.0 ml/min/1.73m² versus -1.0 ml/min/1.73m²; p = 0.032).
Conclusion: At three months after kidney transplantation, graft kidney function remained stable, with no patient mortality and a low rate of acute rejection. The rapid Tacrolimus metabolism associated with an early decline in estimated glomerular filtration rate (eGFR) may inform the development of monitoring strategies and individualized immunosuppressive therapy in clinical practice.
Tài liệu tham khảo
1. Bello AK, Okpechi IG, Levin A, et al., ISN-Global Kidney Health Atlas: A Report by the International Society of Nephrology: An Assessment of Global Kidney Health Care Status Focussing on Capacity, Availability, Accessibility, Affordability and Outcomes of Kidney Disease, 2023.
2. GBD Chronic kidney disease collaboration, “Global, regional, and national burden of chronic kidney disease, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017”, Lancet, 395(10225): 709-33. doi: 10.1016/S0140-6736(20)30045-3, 2020
3. Kasiske BL, Zeier MG, Chapman JR, Craig J, Ekberg H, Garvey CA, et al., “KDIGO clinical practice guideline for the care of kidney transplant recipients”, Am J Transplant, 10(4): S1-136, doi: 10.1111/j.1600-6143.2009.02834, 2010.
4. Hart A, Lentine KL, Smith JM, Miller JM, et al., “OPTN/SRTR 2019 Annual Data Report: Kidney”, American journal of transplantation: official journal of the American Society of Transplantation and the American Society of Transplant Surgeons, 21, doi: 10.1111/ajt.16502, 2021
5. 5. Nguyen Van Quan, Le Thi Kim Phuong, Tran Van Huy, “Evaluation of early results of living donor kidney transplantation at Cho Ray Hospital”, Ho Chi Minh City Medical Journal, 26(1): pp. 123-8, 2022
6. Dharia AA, Huang M, Nash MM, Dacouris N, Prasad GVR, “Post-transplant outcomes in recipients of living donor kidneys and intended recipients of living donor kidneys”, BMC nephrology, 23(1):97, doi: 10.1186/s12882-022-02718-6, 2022.
7. Naesens M, Kuypers DR, Sarwal M, “Calcineurin inhibitor nephrotoxicity”, Clinical Journal of the American Society of Nephrology: CJASN, 4(2): pp. 481-508, doi: 10.2215/cjn.04800908, 2009.
8. Schütte-Nütgen K, Thölking G, Steinke J, Pavenstädt H, et al., “Fast Tac Metabolizers at Risk ⁻ It is Time for a C/D Ratio Calculation”, Journal of Clinical Medicine;8(5). 8(5): p.587 doi: 10.3390/jcm8050587, 2019.
9. Davis S, Gralla J, Klem P, Tong S, et al., “Lower Tacrolimus exposure and time in therapeutic range increase the risk of de novo donor-specific antibodies in the first year of kidney transplantation”, American journal of transplantation: official journal of the American Society of Transplantation and the American Society of Transplant Surgeons, 18(4): pp. 907-15. doi: 10.1111/ajt.14504, 2018.
Tải xuống
Đã Xuất bản
Cách trích dẫn
Số
Chuyên mục
Chấp nhận đăng 16-03-2026
Ngày xuất bản 31-05-2026
